Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.
Clinical trial NCT03224104 · COMPLETED
Trial details
- NCT number
- NCT03224104
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2022-05-05
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.